Posts Tagged 'Triaminic'

Liquid Acetaminophen marketed for infants: Drug Safety Communication – Potential for Dosing Errors

The FDA is informing the public that an additional concentration of liquid acetaminophen marketed for “infants” (160 mg/5 mL) is now available. Giving the wrong dose of acetaminophen can cause the medication to be ineffective if too little is given or cause serious side effects and, possibly, death if too much is given. Acetaminophen is marketed under brand names such as Tylenol, Little Fevers,  Triaminic, Infant/Pain Reliever, Pedia Care, Triaminic Infants’ Syrup Fever Reducer Pain Reliever and other store brands (e.g., Rite Aid, CVS, Walgreens brand, etc.).

Click here to read more…

J&J, Others to Revamp Children’s Pain Drug

In a move to curb overdoses of the pain and fever medicine acetaminophen, Johnson & Johnson and other drug makers will switch to a single concentration in their over-the-counter remedies for infants and children, according to three of the companies. The move will affect J&J’s Tylenol, Triaminic, manufactured by Novartis AG, and generic children’s medicines containing acetaminophen.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 422 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.


Follow

Get every new post delivered to your Inbox.

Join 422 other followers